These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 9710360

  • 1. GH, IGF-I, IGFBP-3 and IGFBP-2 in cerebrospinal fluid of infants, during puberty and in adults.
    Heinze E, Böker M, Blum W, Behnisch W, Schulz A, Urban J, Mauch E.
    Exp Clin Endocrinol Diabetes; 1998; 106(3):197-202. PubMed ID: 9710360
    [Abstract] [Full Text] [Related]

  • 2. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.
    Pirttilä T, Vanhatalo S, Turpeinen U, Riikonen R.
    Acta Neurol Scand; 2004 May; 109(5):337-41. PubMed ID: 15080860
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 4. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.
    Prahalada S, Block G, Handt L, DeBurlet G, Cahill M, Hoe CM, van Zwieten MJ.
    Horm Metab Res; 1999 Dec; 31(2-3):133-7. PubMed ID: 10226793
    [Abstract] [Full Text] [Related]

  • 6. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 7. Serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in healthy Thai children and adolescents: relation to age, sex, and stage of puberty.
    Jaruratanasirikul S, Leethanaporn K, Pradutkanchana S, Sriplung H.
    J Med Assoc Thai; 1999 Mar; 82(3):275-83. PubMed ID: 10410483
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 9. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J, Blum WF, Schenker E, Keller E.
    Exp Clin Endocrinol Diabetes; 1995 May; 103(5):285-91. PubMed ID: 8536056
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y.
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 12. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 13. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Corbo M, Lunetta C, Magni P, Dozio E, Ruscica M, Adobbati L, Silani V.
    Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
    [Abstract] [Full Text] [Related]

  • 14. Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children.
    Bunn RC, King WD, Winkler MK, Fowlkes JL.
    Pediatr Res; 2005 Jul; 58(1):89-93. PubMed ID: 15774848
    [Abstract] [Full Text] [Related]

  • 15. Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis.
    Hoeflich A, Fitzner B, Walz C, Hecker M, Tuchscherer A, Brenmoehl J, Zettl UK.
    Front Endocrinol (Lausanne); 2020 Jul; 11():565557. PubMed ID: 33469444
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    Yaghoobpoor S, Fathi M, Vakili K, Sayehmiri F, Alipour M, Miriran ZS, Ghayyem H, Tutunchian Z, Hajibeygi R, Batool Z, Mirzadeh M, Aghazadeh MH, Hajiesmaeili M.
    PLoS One; 2024 Jul; 19(4):e0297091. PubMed ID: 38630771
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms.
    Riikonen RS, Jääskeläinen J, Turpeinen U.
    Epilepsia; 2010 Jul; 51(7):1283-9. PubMed ID: 20163445
    [Abstract] [Full Text] [Related]

  • 18. Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function.
    Fan D, Alamri Y, Liu K, MacAskill M, Harris P, Brimble M, Dalrymple-Alford J, Prickett T, Menzies O, Laurenson A, Anderson T, Guan J.
    Nutrients; 2018 Jun 02; 10(6):. PubMed ID: 29865234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of pulsed magnetic field on insulin-like growth factor-1 (IGF-1) in cerebrospinal fluid and effects of IGF-1 on functional recovery].
    Song CX, Fan JZ, Wu HY, Wei Y, Zhen JR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct 02; 30(10):2288-90, 2294. PubMed ID: 20965827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.